Interpace Diagnostics Group Reports Second Quarter 2018 Financial Results, Business Progress and Recent Accomplishments

Go back to Interpace Diagnostics Group Reports Second Quarter 2018 Financial Results, Business Progress and Recent Accomplishments

Interpace Diagnostics (IDXG) Tops Q2 EPS by 2c

August 9, 2018 4:56 PM EDT

Interpace Diagnostics (NASDAQ: IDXG) reported Q2 EPS of ($0.07), $0.02 better than the analyst estimate of ($0.09). Revenue for the quarter came in at $5.5 million versus the consensus estimate of $5.04 million.

For earnings history and earnings-related data on Interpace Diagnostics (IDXG) click here.

... More